Carries a conserved CRAL-TRIO domain. Its didtant homologs are cytoplasmic and are involved in antiviral response.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 31 |
NetGPI | no | yes: 0, no: 31 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HJI9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.534 |
CLV_NRD_NRD_1 | 282 | 284 | PF00675 | 0.364 |
CLV_PCSK_FUR_1 | 9 | 13 | PF00082 | 0.386 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.542 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.332 |
CLV_PCSK_PC1ET2_1 | 85 | 87 | PF00082 | 0.239 |
CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.298 |
CLV_PCSK_SKI1_1 | 233 | 237 | PF00082 | 0.349 |
CLV_PCSK_SKI1_1 | 253 | 257 | PF00082 | 0.321 |
CLV_PCSK_SKI1_1 | 283 | 287 | PF00082 | 0.372 |
DEG_SCF_FBW7_1 | 56 | 61 | PF00400 | 0.492 |
DEG_SCF_FBW7_2 | 14 | 21 | PF00400 | 0.424 |
DOC_CYCLIN_RxL_1 | 250 | 257 | PF00134 | 0.165 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 164 | 173 | PF00134 | 0.213 |
DOC_MAPK_gen_1 | 20 | 30 | PF00069 | 0.456 |
DOC_MAPK_gen_1 | 295 | 305 | PF00069 | 0.468 |
DOC_MAPK_HePTP_8 | 235 | 247 | PF00069 | 0.304 |
DOC_MAPK_MEF2A_6 | 224 | 232 | PF00069 | 0.368 |
DOC_MAPK_MEF2A_6 | 238 | 247 | PF00069 | 0.435 |
DOC_USP7_MATH_1 | 297 | 301 | PF00917 | 0.347 |
DOC_USP7_UBL2_3 | 167 | 171 | PF12436 | 0.185 |
DOC_USP7_UBL2_3 | 238 | 242 | PF12436 | 0.352 |
DOC_USP7_UBL2_3 | 336 | 340 | PF12436 | 0.389 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.448 |
DOC_WW_Pin1_4 | 334 | 339 | PF00397 | 0.324 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.501 |
DOC_WW_Pin1_4 | 54 | 59 | PF00397 | 0.486 |
LIG_14-3-3_CanoR_1 | 224 | 232 | PF00244 | 0.373 |
LIG_14-3-3_CanoR_1 | 59 | 67 | PF00244 | 0.432 |
LIG_Actin_WH2_2 | 110 | 127 | PF00022 | 0.237 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.624 |
LIG_deltaCOP1_diTrp_1 | 74 | 81 | PF00928 | 0.475 |
LIG_eIF4E_1 | 65 | 71 | PF01652 | 0.443 |
LIG_FHA_1 | 181 | 187 | PF00498 | 0.464 |
LIG_FHA_1 | 224 | 230 | PF00498 | 0.319 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.436 |
LIG_FHA_1 | 305 | 311 | PF00498 | 0.377 |
LIG_FHA_1 | 340 | 346 | PF00498 | 0.639 |
LIG_FHA_2 | 49 | 55 | PF00498 | 0.553 |
LIG_GBD_Chelix_1 | 116 | 124 | PF00786 | 0.240 |
LIG_LIR_Apic_2 | 150 | 155 | PF02991 | 0.237 |
LIG_LIR_Gen_1 | 276 | 287 | PF02991 | 0.165 |
LIG_LIR_Nem_3 | 139 | 144 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 197 | 203 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 236 | 240 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 276 | 282 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 311 | 317 | PF02991 | 0.165 |
LIG_LIR_Nem_3 | 34 | 38 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 62 | 68 | PF02991 | 0.462 |
LIG_NRBOX | 251 | 257 | PF00104 | 0.272 |
LIG_NRBOX | 41 | 47 | PF00104 | 0.476 |
LIG_Pex14_1 | 200 | 204 | PF04695 | 0.386 |
LIG_SH2_CRK | 152 | 156 | PF00017 | 0.416 |
LIG_SH2_CRK | 279 | 283 | PF00017 | 0.353 |
LIG_SH2_CRK | 35 | 39 | PF00017 | 0.445 |
LIG_SH2_CRK | 68 | 72 | PF00017 | 0.353 |
LIG_SH2_NCK_1 | 68 | 72 | PF00017 | 0.211 |
LIG_SH2_STAT3 | 203 | 206 | PF00017 | 0.331 |
LIG_SH2_STAT3 | 90 | 93 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.536 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.288 |
LIG_SH2_STAT5 | 309 | 312 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 314 | 317 | PF00017 | 0.390 |
LIG_SH2_STAT5 | 65 | 68 | PF00017 | 0.374 |
LIG_SH3_2 | 335 | 340 | PF14604 | 0.554 |
LIG_SH3_3 | 332 | 338 | PF00018 | 0.503 |
LIG_SUMO_SIM_anti_2 | 112 | 118 | PF11976 | 0.226 |
LIG_SUMO_SIM_anti_2 | 272 | 280 | PF11976 | 0.165 |
LIG_SUMO_SIM_anti_2 | 300 | 308 | PF11976 | 0.258 |
LIG_SUMO_SIM_par_1 | 226 | 231 | PF11976 | 0.369 |
LIG_SUMO_SIM_par_1 | 341 | 346 | PF11976 | 0.437 |
LIG_TYR_ITIM | 156 | 161 | PF00017 | 0.407 |
LIG_TYR_ITIM | 235 | 240 | PF00017 | 0.388 |
LIG_TYR_ITIM | 277 | 282 | PF00017 | 0.410 |
LIG_UBA3_1 | 169 | 174 | PF00899 | 0.393 |
LIG_UBA3_1 | 277 | 284 | PF00899 | 0.165 |
MOD_CDC14_SPxK_1 | 337 | 340 | PF00782 | 0.361 |
MOD_CDK_SPK_2 | 54 | 59 | PF00069 | 0.300 |
MOD_CDK_SPxK_1 | 14 | 20 | PF00069 | 0.423 |
MOD_CDK_SPxK_1 | 334 | 340 | PF00069 | 0.336 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.460 |
MOD_CK1_1 | 273 | 279 | PF00069 | 0.429 |
MOD_CK2_1 | 160 | 166 | PF00069 | 0.428 |
MOD_CK2_1 | 349 | 355 | PF00069 | 0.710 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.444 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.235 |
MOD_GlcNHglycan | 272 | 275 | PF01048 | 0.375 |
MOD_GlcNHglycan | 351 | 354 | PF01048 | 0.691 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.481 |
MOD_GSK3_1 | 269 | 276 | PF00069 | 0.277 |
MOD_GSK3_1 | 293 | 300 | PF00069 | 0.352 |
MOD_GSK3_1 | 54 | 61 | PF00069 | 0.496 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.457 |
MOD_N-GLC_1 | 269 | 274 | PF02516 | 0.165 |
MOD_N-GLC_1 | 59 | 64 | PF02516 | 0.459 |
MOD_NEK2_1 | 247 | 252 | PF00069 | 0.340 |
MOD_NEK2_1 | 277 | 282 | PF00069 | 0.316 |
MOD_OFUCOSY | 66 | 73 | PF10250 | 0.228 |
MOD_PIKK_1 | 22 | 28 | PF00454 | 0.452 |
MOD_PKA_2 | 223 | 229 | PF00069 | 0.407 |
MOD_PKA_2 | 297 | 303 | PF00069 | 0.359 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.263 |
MOD_Plk_4 | 224 | 230 | PF00069 | 0.353 |
MOD_Plk_4 | 273 | 279 | PF00069 | 0.300 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.441 |
MOD_ProDKin_1 | 334 | 340 | PF00069 | 0.336 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.507 |
MOD_ProDKin_1 | 54 | 60 | PF00069 | 0.477 |
MOD_SUMO_rev_2 | 15 | 25 | PF00179 | 0.426 |
MOD_SUMO_rev_2 | 163 | 169 | PF00179 | 0.326 |
TRG_DiLeu_BaEn_1 | 301 | 306 | PF01217 | 0.321 |
TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.579 |
TRG_ENDOCYTIC_2 | 141 | 144 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 158 | 161 | PF00928 | 0.378 |
TRG_ENDOCYTIC_2 | 204 | 207 | PF00928 | 0.403 |
TRG_ENDOCYTIC_2 | 237 | 240 | PF00928 | 0.358 |
TRG_ENDOCYTIC_2 | 279 | 282 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 35 | 38 | PF00928 | 0.455 |
TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.340 |
TRG_ER_diArg_1 | 8 | 11 | PF00400 | 0.604 |
TRG_Pf-PMV_PEXEL_1 | 171 | 175 | PF00026 | 0.481 |
TRG_Pf-PMV_PEXEL_1 | 253 | 257 | PF00026 | 0.404 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6D4 | Leptomonas seymouri | 36% | 68% |
A0A0N0P991 | Leptomonas seymouri | 29% | 74% |
A0A0N0P9K9 | Leptomonas seymouri | 25% | 74% |
A0A0N1I2J8 | Leptomonas seymouri | 46% | 76% |
A0A0N1PCS4 | Leptomonas seymouri | 65% | 76% |
A0A0S4J7N0 | Bodo saltans | 25% | 94% |
A0A0S4KJL3 | Bodo saltans | 26% | 78% |
A0A1X0NUJ5 | Trypanosomatidae | 26% | 75% |
A0A3Q8ICN0 | Leishmania donovani | 77% | 71% |
A0A3Q8IGQ2 | Leishmania donovani | 31% | 74% |
A0A3S7X4P4 | Leishmania donovani | 38% | 68% |
A0A3S7X4R1 | Leishmania donovani | 51% | 72% |
A0A422P1E3 | Trypanosoma rangeli | 26% | 76% |
A4HJI7 | Leishmania braziliensis | 40% | 100% |
A4HJI8 | Leishmania braziliensis | 50% | 100% |
A4HKB3 | Leishmania braziliensis | 31% | 74% |
A4HKB4 | Leishmania braziliensis | 26% | 72% |
A4I6Y2 | Leishmania infantum | 38% | 68% |
A4I6Y3 | Leishmania infantum | 51% | 72% |
A4I6Y4 | Leishmania infantum | 77% | 100% |
A4I7U3 | Leishmania infantum | 31% | 74% |
B5MCN3 | Homo sapiens | 22% | 89% |
E9B204 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 68% |
E9B205 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 53% | 72% |
E9B206 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
E9B2Q1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 74% |
O76054 | Homo sapiens | 24% | 88% |
P58875 | Bos taurus | 23% | 88% |
Q4Q5F6 | Leishmania major | 30% | 100% |
Q4Q655 | Leishmania major | 77% | 100% |
Q4Q656 | Leishmania major | 51% | 100% |
Q4Q657 | Leishmania major | 39% | 100% |
Q8R0F9 | Mus musculus | 21% | 88% |
Q99J08 | Mus musculus | 24% | 88% |
Q99MS0 | Rattus norvegicus | 24% | 88% |
Q9UDX3 | Homo sapiens | 23% | 87% |
Q9UDX4 | Homo sapiens | 22% | 89% |
Q9Z1J8 | Rattus norvegicus | 22% | 89% |
V5BL84 | Trypanosoma cruzi | 28% | 77% |